Comparison of the Effect of Ketamine Infusion with Dexmedetomidine Infusion during Postoperative Fusion of Lumbar Vertigo in Acute Post-Operative Pain.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180723040570N2

Enrollment

Registered

2019-08-14

Start date

2019-08-05

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior fusion surgery of the lumbar spine. Nerve root and plexus disorders

Interventions

Intervention 1: Intervention group1: ketamin Infusion is administered as an infusion at a dose of 0.1 mg / kg per hour.The consumable ketamines are all manufactured by Rotex Germany.As mentioned, the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Entry criteria included candidates for PSF surgery and ASA1 or ASA2

Exclusion criteria

Exclusion criteria: history of the disease Psychiatry systemic diseases such as heart failure, liver, kidney, lung infectious disorder conciousness abnormalities addicted patients

Design outcomes

Primary

Measure	Time frame
Acute pain after surgery. Timepoint: Enter your recovery & 2&4&6&12 after surjery. Method of measurement: pain ruler.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasim Nikoubakht

Iran University of Medical Sciences

nikoobakht.n@iums.ac.ir+98 21 8862 9854

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026